Yini Li

Yini Li

Auto-generated profile, based on publicly available information

Yini Li

Pathology, Johns Hopkins School of Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2023 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
XDXiaoyang Dou
Xiaoyang Dou
YXYu Xiao
Yu Xiao
CSChao Shen
Chao Shen
KWKitty Wang
Kitty Wang
TWTong Wu
Tong Wu
CHChuan He
Chuan He
N6-methyladenosine (m6A) methylation can be deposited on chromatin-associated RNAs (caRNAs) by the RNA methyltransferase complex (MTC) to regulate chromatin state and transcription. However, the mechanism by which MTC is recruited to distinct genomic loci remains elusive. Here we identify RBFOX2, a well-studied RNA-binding protein, as a chromatin factor that preferentially recognizes m6A on caRNAs. RBFOX2 can recruit RBM15, an MTC component, to facilitate methylation of promoter-associated RNAs. RBM15 also physically interacts with YTHDC1 and recruits polycomb repressive complex 2 (PRC2) to the RBFOX2-bound loci for chromatin silencing and transcription suppression. Furthermore, we found that this RBFOX2/m6A/RBM15/YTHDC1/PRC2 axis plays a critical role in myeloid leukaemia. Downregulation of RBFOX2 notably inhibits survival/proliferation of acute myeloid leukaemia cells and promotes their myeloid differentiation. RBFOX2 is also required for self-renewal of leukaemia stem/initiation cells and acute myeloid leukaemia maintenance. Our study presents a pathway of m6A MTC recruitment and m6A deposition on caRNAs, resulting in locus-selective chromatin regulation, which has potential therapeutic implications in leukaemia.

26 June 2023 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YLYini Li
Yini Li
XDXiaoyang Dou
Xiaoyang Dou
JLJun Liu
Jun Liu
YXYu Xiao
Yu Xiao
ZZZhe Zhang
Zhe Zhang
SSShuying Sun
Shuying Sun

1 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJonathan P. Ling
Jonathan P. Ling
ABAlexei M. Bygrave
Alexei M. Bygrave
CSClayton P. Santiago
Clayton P. Santiago
RCRogger P. Carmen-Orozco
Rogger P. Carmen-Orozco
VTVickie T. Trinh
Vickie T. Trinh
SBSeth Blackshaw
Seth Blackshaw
Precise and reliable cell-specific gene delivery remains technically challenging. Here we report a splicing-based approach for controlling gene expression whereby separate translational reading frames are coupled to the inclusion or exclusion of mutated, frameshifting cell-specific alternative exons. Candidate exons are identified by analyzing thousands of publicly available RNA sequencing datasets and filtering by cell specificity, conservation, and local intron length. This method, which we denote splicing-linked expression design (SLED), can be combined in a Boolean manner with existing techniques such as minipromoters and viral capsids. SLED can use strong constitutive promoters, without sacrificing precision, by decoupling the tradeoff between promoter strength and selectivity. AAV-packaged SLED vectors can selectively deliver fluorescent reporters and calcium indicators to various neuronal subtypes in vivo. We also demonstrate gene therapy utility by creating SLED vectors that can target PRPH2 and SF3B1 mutations. The flexibility of SLED technology enables creative avenues for basic and translational research.

6 August 2024 in Science Signaling
Verified
Journal Article
Open access
DDDaoyuan Dong
Daoyuan Dong
ZZZhe Zhang
Zhe Zhang
YLYini Li
Yini Li
MLMalgorzata J. Latallo
Malgorzata J. Latallo
Shaopeng WangShaopeng Wang
Shaopeng Wang
SSShuying Sun
Shuying Sun
Hexanucleotide repeat expansion in the C9ORF72 gene is the most frequent inherited cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The expansion results in multiple dipeptide repeat proteins, among which arginine-rich poly-GR proteins are highly toxic to neurons and decrease the rate of protein synthesis. We investigated whether the effect on protein synthesis contributes to neuronal dysfunction and degeneration. We found that the expression of poly-GR proteins inhibited global translation by perturbing translation elongation. In iPSC-differentiated neurons, the translation of transcripts with relatively slow elongation rates was further slowed, and stalled, by poly-GR. Elongation stalling increased ribosome collisions and induced a ribotoxic stress response (RSR) mediated by ZAKα that increased the phosphorylation of the kinase p38 and promoted cell death. Knockdown of ZAKα or pharmacological inhibition of p38 ameliorated poly-GR–induced toxicity and improved the survival of iPSC–derived neurons from patients with C9ORF72 -ALS/FTD. Our findings suggest that targeting the RSR may be neuroprotective in patients with ALS/FTD caused by repeat expansion in C9ORF72 .

29 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ISIrika R. Sinha
Irika R. Sinha
YYYingzhi Ye
Yingzhi Ye
YLYini Li
Yini Li
PSParker S. Sandal
Parker S. Sandal
PWPhilip C. Wong
Philip C. Wong
JLJonathan P. Ling
Jonathan P. Ling
TAR DNA-binding protein 43 kDa (TDP-43) is an essential splicing repressor whose loss of function underlies the pathophysiology of amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). Nuclear clearance of TDP-43 disrupts its function and leads to the inclusion of aberrant cryptic exons. These cryptic exons frequently introduce premature termination codons resulting in the degradation of affected transcripts through nonsense-mediated mRNA decay (NMD). Conventional RNA sequencing approaches thus may fail to detect cryptic exons that are efficiently degraded by NMD, precluding identification of potential therapeutic targets. We generated a comprehensive set of neuronal targets of TDP-43 in human iPSC-derived i 3 Neurons (i 3 N) by combining TDP-43 knockdown with inhibition of multiple factors essential for NMD, revealing novel cryptic targets. We then restored expression of selected NMD targets in TDP-43 deficient i 3 Ns and determined which genes improved neuronal viability. Our findings highlight the role of NMD in masking cryptic splicing events and identify novel potential therapeutic targets for TDP-43-related neurodegenerative disorders.

24 March 2022 in Research Square
Verified
Preprint
Open access
PDF file
SBSeth Blackshaw
Seth Blackshaw
JLJonathan Ling
Jonathan Ling
ABAlexei Bygrave
Alexei Bygrave
CSClayton Santiago
Clayton Santiago
RCRogger Carmen-Orozco
Rogger Carmen-Orozco
RHRichard Huganir
Richard Huganir
Precise cell-specific gene delivery remains technically challenging. Here we report a splicing-based approach whereby separate translational reading frames are coupled to the inclusion or exclusion of cell-specific alternative exons. Candidate exons are identified by analyzing publicly available RNA sequencing datasets and filtering by cell specificity, sequence conservation, and intron length. This method, which we term splicing-linked expression design (SLED), can be combined in a Boolean manner with existing minipromoters and viral serotypes. We generated AAV-based SLED vectors that selectively target all neurons, photoreceptors, or excitatory neurons. We further used SLED to generate a GluA2 flip/flop reporter and a dual excitatory/inhibitory neuronal calcium indicator. Finally, we show the translational potential of SLED by rescuing photoreceptor degeneration in Prph2rds/rds mice and by developing an oncolytic vector that can selectively induce apoptosis in SF3B1 mutant cancer cells. The flexibility of SLED technology enables new avenues for basic and translational research.